web analytics
August 27, 2014 / 1 Elul, 5774
At a Glance
News & Views
Sponsored Post
Jerusalem Mayor Nir Barkat (L) visits the JewishPress.com booth at The Event. And the Winners of the JewishPress.com Raffle Are…

Congratulations to all the winners of the JewishPress.com raffle at The Event



Teva’s Parkinson Drug Now Marketed in Japan

Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.

The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.

“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.

“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.

“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.

Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.

Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.

Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.

According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.

“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.

About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

2 Responses to “Teva’s Parkinson Drug Now Marketed in Japan”

  1. Judith Dowla says:

    TEVA is an excellent pharmaceutical company that offers a considerable amount of funds into research and is on the leading edge in finding the best possible treatment for various diseases and with a focus as well on receptors involving the nerves that become disturbed via a variety of causes. The goal is to do what is best to help the patient overcome and manage the disturbances that can make life very uncomfortable. Keep up the good work TEVA.

Comments are closed.

SocialTwist Tell-a-Friend

Current Top Story
Strike on Golan Yekev
Israeli Wounded from Syrian Shelling on Golan
Latest News Stories
Strike on Golan Yekev

This shot may have come from a Syrian tank…

Engineering Corp soldier looking down a Palestinian-dug tunnel.

Hamas recently indicated to international press that it would continue building up its underground network while restocking arsenal, rockets and other weaponry

Teh Iranian weapons ship Klos C

Iran vowed on Monday to “accelerate” its rearming of PA Arabs in Judea and Samaria, one day after it claimed that it shot down an Israeli spy drone over its airspace.

Fears for the life of New Jersey yeshiva student Aaron Sofer, studying in Israel, grow with each passing day since his disappearance on Friday.

The case of missing U.S. yeshiva student Aaron Sofer, studying in Israel, remains unsolved after six days.

“We are strong chassidic women and we take the name, we embrace it, and we own it.”

After a month, should the quiet hold, Israel and Hamas will restart indirect negotiations in Cairo on easing Israel’s blockade of the coastal strip and disarming the enclave.

Israel’s political landscape awoke Wednesday to the latest ceasefire with a sharp round of criticism for Prime Minister Netanyahu, and jostling for position amongst senior politicians who have begun to smell the aroma of early elections, possibly in the first half of 2015.

Palestinian terrorists threw stones at Jewish-owned cars in the Wadi Joz section of Jerusalem Wednesday. Three children were injured and treated on the spot. A 22-year-old man was arrested, and police told Israel Radio the man has confessed to other incidents as well. In Shuafat, in northern Jerusalem, Palestinians threw rocks at the Jerusalem light […]

Nearly 90 percent of Gaza residents support attacks on Israel, say rockets help ‘deterrence’

Chaim Yellin: We don’t want government support. We need quiet in the morning.

Mortar fire crossed the border into northern Israel from Syria near Quneitra. Two cars were damaged. Accidental shelling?

NYC lawmaker Laurie Cumbo presses Miami-Dade officials to find Rabbi Joseph Raksin’s murderer.

Former US Middle East envoy Martin Indyk warns Israel’s self-defense in Gaza has increased tensions with Washington – again.

A baby was hurt when Palestinian terrorists stoned the car she was driving in near the Samaria community of Yitzhar this morning. According to reports on the Hebrew-language 0404 website, the driver of the vehicle escaped the scene of the attack and reached a nearby IDF base safely. There, the baby was treated for her […]

The Zara clothing firm fell ‘fashion flat’ with a toddler tee allegedly a “sheriff’s shirt” in Israel – bearing a yellow, 6-pointed star.

The majority of the reactions are against the truce, and all voiced skepticism about its viability.

More Articles from Anav Silverman, Tazpit News Agency
Engineering Corp soldier looking down a Palestinian-dug tunnel.

Hamas recently indicated to international press that it would continue building up its underground network while restocking arsenal, rockets and other weaponry

Shahar Shalev

“We are in vital need of men aged 18-60 who are willing to donate platelets.”

Israel continues to provide humanitarian assistance to Palestinians in the Gaza Strip no matter if Hamas is in a state of war or truce against the Jewish state.

A contingent of New York government officials and businessmen are spending three days in Israel on a unity visit this week.

The presence of the Islamic State of Iraq and Syria (ISIS) has begun to grow in the Gaza Strip, with both the PA and Israel convinced that followers of ISIS in Gaza have been responsible for some of the rocket attacks on Israel.

BGU Researchers Discover New Computerized Method to Profile Personalities of Political Leaders

    Latest Poll

    Do you think the FAA ban on US flights to Israel is political?






    View Results

    Loading ... Loading ...

Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/

Scan this QR code to visit this page online: